On January 19, 2021 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that senior leadership plans to present at the following virtual healthcare conferences (Press release, Iovance Biotherapeutics, JAN 19, 2021, View Source [SID1234574107]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
B. Riley Oncology Investor Conference
Date/Time: Wednesday, January 20, 2021 at 1:00 p.m. ET
The live and archived webcast of the presentation will be available in the Investors section of the Iovance website at View Source
Guggenheim Healthcare Talks Oncology Days
Date/Time: Thursday, February 11, at 12:00 p.m. ET
The live and archived webcast of the presentation will be available in the Investors section of the Iovance website at View Source
7th Annual Immuno-Oncology 360° Conference – Event Information
Panel Title: Biotech CEO Leadership on the Business and Science of Cell and Gene Therapy
Date/Time: Tuesday, February 23, at 11:10 a.m. ET
Presentation Title: Tumor Infiltrating Lymphocyte Cell Therapy for Treatment of Solid Tumors
Date/Time: Tuesday, February 23, at 1:45 p.m. ET